MAP4K4 implication in HGF-induced internalization of membrane transport proteins and drug transporters (31) indicated a potential therapeutic benefit of targeting this function of MAP4K4 during chemotherapy, which remains one of the first-line treatments for cancer patients. The gene discussed is HGF; the disease is cancer.